Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Income (Loss) Per Share

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per share of Class A common stock is as follows:


	Three months ended Mar. 31,
(in thousands, except per share amounts)		2026		2025
Numerator:
Net income (loss)		$	(66,136)	$	(9,786)
Less: Net income (loss) attributable to non-controlling interests		(28,965)		(5,378)
Net income (loss) attributable to GoHealth, Inc.		(37,171)		(4,408)
Less: Dividends accumulated on redeemable convertible preferred stock		1,024		956
Net income (loss) attributable to common stockholders - basic		(38,195)		(5,364)




Denominator:
Weighted-average shares of Class A common stock outstanding—basic and diluted		16,196		10,373





Net income (loss) per share of Class A common stock—basic		$	(2.36)	$	(0.52)
Net income (loss) per share of Class A common stock—diluted		$	(2.36)	$	(0.52)

Schedule of Antidilutive Securities Excluded From Calculation of Diluted Income (Loss) Per Share

The following number of shares were excluded from the calculation of diluted income (loss) per share of Class A common stock because the effect of including such potentially dilutive shares would have been antidilutive:


	Mar. 31,
(in thousands)	2026	2025
Equity awards	3,009	2,307
Redeemable convertible preferred stock	5,219	4,113
Class B common stock	12,616	12,623